PharmGen Science, Inc. Logo

PharmGen Science, Inc.

004720 | KO

Overview

Corporate Details

ISIN(s):
KR7004720009
LEI:
Country:
South Korea
Address:
경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-19 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-12 00:00
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 15.9 KB
2025-06-12 00:00
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 14.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.8 MB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-04-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.0 KB
2025-04-11 00:00
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 14.4 KB
2025-04-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 677.5 KB
2025-04-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-03 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 34.9 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 28.6 KB

Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmGen Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ELUTIA INC. Logo
Develops drug-eluting biologics to reduce complications from medical implants.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and manufactures medical countermeasures for public health and national security threats.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
United States of America
ENTA
Enervit Logo
Produces sports nutrition & wellness supplements for athletes and active lifestyles.
Italy
ENV
enGene Holdings Inc. Logo
Developing non-viral, locally administered gene therapies for rare genetic conditions.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
A clinical-stage biopharma developing kinase inhibitors for precision oncology cancer treatment.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy that reprograms macrophages to treat immune hyper-responses like sepsis.
United States of America
ENLV
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel
ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610

Talk to a Data Expert

Have a question? We'll get back to you promptly.